OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
Wei Chen, Zhihao Wang, Yawen Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10

Showing 10 citing articles:

Inhibitors of SARS-CoV-2 PLpro
Dale J. Calleja, Guillaume Lessène, David Komander
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 63

Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications
Chiara Ceresa, Letizia Fracchia, Andrea Chiara Sansotera, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2156-2156
Open Access | Times Cited: 20

Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies
Rahman Abdizadeh, Farzin Hadizadeh, Tooba Abdizadeh
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 13, pp. 5915-5945
Closed Access | Times Cited: 12

Harnessing the Potential of Biosurfactants for Biomedical and Pharmaceutical Applications
Chiara Ceresa, Letizia Fracchia, Andrea Chiara Sansotera, et al.
(2023)
Open Access | Times Cited: 6

Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants
Lei He, Qian Wu, Zhaoyong Zhang, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1

Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
Imra Aqeel, Muhammad Bilal, Abdul Majid, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1333-1333
Open Access | Times Cited: 8

Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review
Mariana Martinelli Junqueira Ribeiro
Current Computer - Aided Drug Design (2023) Vol. 20, Iss. 4, pp. 313-324
Closed Access | Times Cited: 2

Repositioned Natural Compounds and Nanoformulations: A Promising Combination to Counteract Cell Damage and Inflammation in Respiratory Viral Infections
Alessia Mariano, Irene Bigioni, М. Marchetti, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4045-4045
Open Access | Times Cited: 2

COVID-19 Therapies: Protease Inhibitions and Novel Degrader Strategies
Michèle Reboud‐Ravaux, Chahrazade El Amri
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 3

Efficacy Evaluation of Quercetin and Its Analogues on the Main Protease Enzyme of the COVID-19 Using Molecular Docking Studies
Tooba Abdizadeh
journal of ilam university of medical sciences (2022) Vol. 30, Iss. 4, pp. 66-85
Open Access

Page 1

Scroll to top